Clinical Trial Update: Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating anti-thymocyte globulin and cyclosporine as first-line therapy for severe aplastic anemia completed with posted results in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• anti-thymocyte globulin (antithymocyte globulin)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Aplastic Anemia | Phase 2 | Status: COMPLETED | Results posted: 2012-03-09